OncoRes Medical is thrilled to announce the appointment of Renee Ryan as Non-Executive Director to the Company’s Board.
With more than 25 years building and scaling healthcare and medical technology companies, she brings an extraordinary depth of expertise and leadership. Ms Ryan previously led health technology investments for Johnson & Johnson Innovation (JJDC) across the West Coast and Asia Pacific, where she made over 15 new investments, including leading the Series A for Cala Health. She later stepped into the role of CEO and Board member of Cala Health and today continues to shape the future of medtech as a Board member of RefleXion Medical and Neuropace.
Her appointment comes as OncoRes advances toward clinical and regulatory milestones and prepares for commercial expansion.